Human Dermal Stem/Progenitor Cell-Derived Conditioned Medium Improves Senescent Human Dermal Fibroblasts.

Area of Science:

• Dermatology
• Cell Biology
• Regenerative Medicine

Background:

• Adult skin stem cells show potential for skin rejuvenation.
• Human dermal stem/progenitor cells (hDSPCs) can be isolated using collagen type IV.
• The impact of hDSPCs on cellular senescence requires further investigation.

Purpose of the Study:

• To investigate the effects of conditioned medium from hDSPC cultures (hDSPC-CM) on senescent fibroblasts.
• To determine if hDSPC-CM can mitigate the hallmarks of skin aging at a cellular level.

Main Methods:

• Senescent fibroblasts were treated with hDSPC-CM.
• Cell proliferation, senescence-associated β-galactosidase activity, p53 phosphorylation, and p21 expression were assessed.
• Expression levels of collagen type I, collagen type III, tissue inhibitor of metalloproteinase, matrix metalloproteinase 1, and superoxide dismutase 2 were analyzed.
• Reactive oxygen species (ROS) levels were measured.

Main Results:

• hDSPC-CM enhanced senescent fibroblast proliferation and reduced senescence markers.
• Treatment with hDSPC-CM decreased p53 phosphorylation and p21 expression.
• hDSPC-CM normalized collagen and tissue inhibitor of metalloproteinase expression while reducing matrix metalloproteinase 1.
• hDSPC-CM significantly lowered ROS levels by up-regulating superoxide dismutase 2.

Conclusions:

• hDSPC-CM demonstrates significant anti-aging effects on senescent fibroblasts.
• hDSPC-CM promotes skin rejuvenation by improving cellular function and extracellular matrix integrity.
• hDSPC-CM presents a promising therapeutic strategy for treating aged human skin.